speb/financial-data huggingface dataset:
CARE balance_sheet (quarterly, 2025-09-30) — Common Stock: 22406000.00
CARE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 412838000.00
CARE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -4904000.00
CARE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -490000.00
CARE cash_flow (quarterly, 2025-09-30) — Deferred Tax: -490000.00
CARE cash_flow (quarterly, 2025-09-30) — Depreciation: 1965000.00
CARE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1965000.00
CARE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1965000.00
CARE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 22294228.00
CARE income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.24
CARE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 5351000.00
CARE cash_flow (quarterly, 2025-09-30) — End Cash Position: 106948000.00
CARE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 45204000.00
CARE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 10276000.00
CARE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
CARE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 0.00
CARE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -46053000.00
CARE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 15473000.00
CARE balance_sheet (quarterly, 2025-09-30) — Goodwill: 1193000.00
CARE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2200000.00
CARE cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1646000.00
CARE income_statement (quarterly, 2025-09-30) — Insurance And Claims: 1450000.00
CARE income_statement (quarterly, 2025-09-30) — Interest Expense: 25451000.00
CARE income_statement (quarterly, 2025-09-30) — Interest Income: 59026000.00
CARE cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 25061000.00
CARE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 588338000.00
CARE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -49976000.00
CARE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 674568000.00
CARE cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 217000000.00
CARE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 175500000.00
CARE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 175500000.00
CARE cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 217000000.00
CARE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -155000000.00
CARE balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 3072000.00
CARE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CARE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -4904000.00
CARE balance_sheet (quarterly, 2025-09-30) — Net Debt: 68552000.00
CARE income_statement (quarterly, 2025-09-30) — Net Income: 5419000.00
CARE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 5351000.00
CARE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 5419000.00
CARE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 5419000.00
CARE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 5419000.00
CARE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 5419000.00
CARE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 5419000.00
CARE income_statement (quarterly, 2025-09-30) — Net Interest Income: 33575000.00
CARE cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: 906000.00
CARE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 34493000.00
CARE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 62000000.00
CARE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 62000000.00
CARE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 4328000.00
CARE balance_sheet (quarterly, 2025-09-30) — Net PPE: 71653000.00
CARE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1539000.00
CARE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 410638000.00
CARE income_statement (quarterly, 2025-09-30) — Normalized Income: 5419000.00
CARE balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 63604000.00
CARE income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 4582000.00
CARE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 11815000.00
CARE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -28000.00
CARE income_statement (quarterly, 2025-09-30) — Operating Revenue: 38130000.00
CARE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 22406406.00
CARE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -46053000.00
CARE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1007000.00
CARE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -193000.00
CARE income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 5169000.00
CARE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 664299000.00
CARE income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 68000.00
CARE income_statement (quarterly, 2025-09-30) — Pretax Income: 7154000.00
CARE income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 1852000.00
CARE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -5307000.00
CARE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1539000.00
CARE balance_sheet (quarterly, 2025-09-30) — Receivables: 63604000.00
CARE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1965000.00
CARE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -155000000.00
CARE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -4904000.00
CARE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 356488000.00
CARE income_statement (quarterly, 2025-09-30) — Salaries And Wages: 14023000.00
CARE cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CARE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 39800000.00
CARE cash_flow (quarterly, 2025-09-30) — Sale Of Investment Properties: 906000.00
CARE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 669000.00
CARE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 16142000.00
CARE balance_sheet (quarterly, 2025-09-30) — Share Issued: 22406406.00
CARE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 539000.00
CARE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 412838000.00
CARE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 410638000.00
CARE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (quarterly, 2025-09-30) — Tax Provision: 1735000.00
CARE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
CARE balance_sheet (quarterly, 2025-09-30) — Total Assets: 4840119000.00
CARE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 588338000.00
CARE balance_sheet (quarterly, 2025-09-30) — Total Debt: 175500000.00
CARE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 412838000.00
CARE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4427281000.00
CARE cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -69000.00
CARE income_statement (annual, 2025-12-31) — +Total Revenue: 149032000.00
CARE income_statement (quarterly, 2025-12-31) — +Total Revenue: 38579000.00
CARE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -48289000.00
CARE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -48289000.00
CARE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 74806000.00
CARE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 74806000.00
CARE cash_flow (annual, 2025-12-31) — Amortization Of Securities: 3172000.00
CARE cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 681000.00
CARE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 318395000.00
CARE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 318395000.00
CARE income_statement (annual, 2025-12-31) — Basic Average Shares: 22456705.00
CARE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 21857904.00
CARE income_statement (annual, 2025-12-31) — Basic EPS: 1.38
CARE income_statement (quarterly, 2025-12-31) — Basic EPS: 0.38
CARE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 131171000.00
CARE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 106948000.00
CARE cash_flow (annual, 2025-12-31) — Capital Expenditure: -8055000.00
CARE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -3076000.00
CARE balance_sheet (annual, 2025-12-31) — Capital Stock: 22083000.00
CARE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 22083000.00
CARE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 105163000.00
CARE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 105163000.00
CARE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 121993000.00
CARE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 121993000.00
CARE balance_sheet (annual, 2025-12-31) — Cash Financial: 36936000.00
CARE balance_sheet (quarterly, 2025-12-31) — Cash Financial: 36936000.00
CARE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 90041000.00
CARE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2416000.00
CARE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -155911000.00
CARE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11441000.00
CARE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 39862000.00
CARE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 12072000.00
CARE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 1859000.00
CARE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -702000.00
CARE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -2329000.00
CARE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 2200000.00
CARE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1511000.00
CARE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -456000.00
CARE cash_flow (annual, 2025-12-31) — Change In Working Capital: -1981000.00
CARE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1042000.00
CARE cash_flow (annual, 2025-12-31) — Changes In Cash: -26008000.00
CARE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1785000.00
CARE balance_sheet (annual, 2025-12-31) — Common Stock: 22083000.00
CARE balance_sheet (quarterly, 2025-12-31) — Common Stock: 22083000.00
CARE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 419697000.00
CARE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 419697000.00
CARE cash_flow (annual, 2025-12-31) — Common Stock Payments: -20000000.00
CARE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -5958000.00
CARE cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2820000.00
CARE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 1357000.00
CARE cash_flow (annual, 2025-12-31) — Deferred Tax: 2820000.00
CARE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 1357000.00
CARE cash_flow (annual, 2025-12-31) — Depreciation: 7859000.00
CARE cash_flow (quarterly, 2025-12-31) — Depreciation: 2044000.00
CARE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 7859000.00
CARE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2044000.00
CARE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 7859000.00
CARE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2044000.00
CARE income_statement (annual, 2025-12-31) — Diluted Average Shares: 22456705.00
CARE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 21857904.00
CARE income_statement (annual, 2025-12-31) — Diluted EPS: 1.38
CARE income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.38
CARE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 8741000.00
CARE cash_flow (annual, 2025-12-31) — End Cash Position: 105163000.00
CARE cash_flow (quarterly, 2025-12-31) — End Cash Position: 105163000.00
CARE cash_flow (annual, 2025-12-31) — Financing Cash Flow: 90041000.00
CARE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2416000.00
CARE cash_flow (annual, 2025-12-31) — Free Cash Flow: 31807000.00
CARE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 8996000.00
CARE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -46000.00
CARE cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -46000.00
CARE income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 46000.00
CARE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 46000.00
CARE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -42160000.00
CARE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -42160000.00
CARE income_statement (annual, 2025-12-31) — General And Administrative Expense: 63586000.00
CARE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 17508000.00
CARE balance_sheet (annual, 2025-12-31) — Goodwill: 1193000.00
CARE balance_sheet (quarterly, 2025-12-31) — Goodwill: 1193000.00
CARE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2133000.00
CARE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2133000.00
CARE balance_sheet (annual, 2025-12-31) — Gross PPE: 120786000.00
CARE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 120786000.00
CARE cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3717000.00
CARE cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 577000.00
CARE income_statement (annual, 2025-12-31) — Insurance And Claims: 5843000.00
CARE income_statement (quarterly, 2025-12-31) — Insurance And Claims: 1527000.00
CARE income_statement (annual, 2025-12-31) — Interest Expense: 101402000.00
CARE income_statement (quarterly, 2025-12-31) — Interest Expense: 24694000.00
CARE income_statement (annual, 2025-12-31) — Interest Income: 231606000.00
CARE income_statement (quarterly, 2025-12-31) — Interest Income: 59078000.00
CARE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 102649000.00
CARE cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 24788000.00
CARE balance_sheet (annual, 2025-12-31) — Invested Capital: 598197000.00
CARE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 598197000.00
CARE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -155911000.00
CARE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11441000.00
CARE balance_sheet (annual, 2025-12-31) — Investments And Advances: 701903000.00
CARE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 701903000.00
CARE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 610000000.00
CARE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 148000000.00
CARE balance_sheet (annual, 2025-12-31) — Land And Improvements: 17783000.00
CARE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 17783000.00
CARE balance_sheet (annual, 2025-12-31) — Leases: 3156000.00
CARE balance_sheet (quarterly, 2025-12-31) — Leases: 3156000.00
CARE balance_sheet (annual, 2025-12-31) — Long Term Debt: 178500000.00
CARE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 178500000.00
CARE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 178500000.00
CARE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 178500000.00
CARE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 610000000.00
CARE cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 148000000.00
CARE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -501500000.00
CARE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -145000000.00
CARE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 2992000.00
CARE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 2992000.00
CARE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 39389000.00
CARE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 39389000.00
CARE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 53573000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CARE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -20000000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -5958000.00
CARE balance_sheet (annual, 2025-12-31) — Net Debt: 73337000.00
CARE balance_sheet (quarterly, 2025-12-31) — Net Debt: 73337000.00
CARE income_statement (annual, 2025-12-31) — Net Income: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Net Income: 8480000.00
CARE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 8741000.00
CARE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 8480000.00
CARE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 8480000.00
CARE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 8480000.00
CARE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 31362000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 8480000.00
CARE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 8480000.00
CARE income_statement (annual, 2025-12-31) — Net Interest Income: 130204000.00
CARE income_statement (quarterly, 2025-12-31) — Net Interest Income: 34384000.00
CARE cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 1618000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: 239000.00
CARE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 52249000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 40628000.00
CARE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 108500000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 3000000.00
CARE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 108500000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 3000000.00
CARE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 7000.00
CARE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -5232000.00
CARE balance_sheet (annual, 2025-12-31) — Net PPE: 72497000.00
CARE balance_sheet (quarterly, 2025-12-31) — Net PPE: 72497000.00
CARE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -8055000.00
CARE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -3076000.00
CARE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 417564000.00
CARE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 417564000.00
CARE income_statement (annual, 2025-12-31) — Normalized Income: 31362000.00
CARE income_statement (quarterly, 2025-12-31) — Normalized Income: 8480000.00
CARE income_statement (annual, 2025-12-31) — Occupancy And Equipment: 17620000.00
CARE income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 4336000.00
CARE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 39862000.00
CARE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 12072000.00
CARE cash_flow (annual, 2025-12-31) — Operating Gains Losses: 44000.00
CARE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -84000.00
CARE income_statement (annual, 2025-12-31) — Operating Revenue: 149032000.00
CARE income_statement (quarterly, 2025-12-31) — Operating Revenue: 38579000.00
CARE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 22083007.00
CARE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 22083007.00
CARE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -42160000.00
CARE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -42160000.00
CARE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 940000.00
CARE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 940000.00
CARE cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1404000.00
CARE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 310000.00
CARE income_statement (annual, 2025-12-31) — Other Non Interest Expense: 21608000.00
CARE income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 5153000.00
CARE balance_sheet (annual, 2025-12-31) — Other Properties: 60458000.00
CARE balance_sheet (quarterly, 2025-12-31) — Other Properties: 60458000.00
CARE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 383508000.00
CARE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 383508000.00
CARE income_statement (annual, 2025-12-31) — Pretax Income: 40001000.00
CARE income_statement (quarterly, 2025-12-31) — Pretax Income: 11083000.00
CARE income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 6877000.00
CARE income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 1874000.00
CARE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -63684000.00
CARE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -5060000.00
CARE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -8055000.00
CARE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -3076000.00
CARE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 7859000.00
CARE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2044000.00
CARE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -501500000.00
CARE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -145000000.00
CARE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -20000000.00
CARE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -5958000.00
CARE balance_sheet (annual, 2025-12-31) — Retained Earnings: 364968000.00
CARE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 364968000.00
CARE income_statement (annual, 2025-12-31) — Salaries And Wages: 57743000.00
CARE income_statement (quarterly, 2025-12-31) — Salaries And Wages: 15981000.00
CARE cash_flow (annual, 2025-12-31) — Sale Of Business: 53573000.00
CARE cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CARE cash_flow (annual, 2025-12-31) — Sale Of Investment: 115933000.00
CARE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 45688000.00
CARE cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 1618000.00
CARE cash_flow (quarterly, 2025-12-31) — Sale Of Investment Properties: 239000.00
CARE income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 3171000.00
CARE income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 883000.00
CARE income_statement (annual, 2025-12-31) — Selling General And Administration: 66757000.00
CARE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 18391000.00
CARE balance_sheet (annual, 2025-12-31) — Share Issued: 22083007.00
CARE balance_sheet (quarterly, 2025-12-31) — Share Issued: 22083007.00
CARE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2071000.00
CARE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 522000.00
CARE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 419697000.00
CARE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 419697000.00
CARE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 417564000.00
CARE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 417564000.00
CARE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (annual, 2025-12-31) — Tax Provision: 8639000.00
CARE income_statement (quarterly, 2025-12-31) — Tax Provision: 2603000.00
CARE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.22
CARE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
CARE balance_sheet (annual, 2025-12-31) — Total Assets: 4851922000.00
CARE balance_sheet (quarterly, 2025-12-31) — Total Assets: 4851922000.00
CARE balance_sheet (annual, 2025-12-31) — Total Capitalization: 598197000.00
CARE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 598197000.00
CARE balance_sheet (annual, 2025-12-31) — Total Debt: 178500000.00
CARE balance_sheet (quarterly, 2025-12-31) — Total Debt: 178500000.00
CARE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 419697000.00
CARE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 419697000.00
CARE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4432225000.00
CARE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4432225000.00
CARE cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -250000.00
CARE cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -22000.00
CARE income_statement (quarterly, 2026-03-31) — +Total Revenue: 105907000.00
CARE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 74987000.00
CARE cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 629000.00
CARE balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 316728000.00
CARE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 21846942.00
CARE income_statement (quarterly, 2026-03-31) — Basic EPS: 3.88
CARE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 105163000.00
CARE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1537000.00
CARE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 22160000.00
CARE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 228318000.00
CARE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 236794000.00
CARE balance_sheet (quarterly, 2026-03-31) — Cash Financial: 36961000.00
CARE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -154139000.00
CARE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -26621000.00
CARE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 303915000.00
CARE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 2512000.00
CARE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 16201000.00
CARE cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -436000.00
CARE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 18277000.00
CARE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 123155000.00
CARE balance_sheet (quarterly, 2026-03-31) — Common Stock: 22160000.00
CARE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 504902000.00
CARE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 6289000.00
CARE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 6289000.00
CARE cash_flow (quarterly, 2026-03-31) — Depreciation: 2132000.00
CARE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2132000.00
CARE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2132000.00
CARE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 21846942.00
CARE income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.88
CARE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 84688000.00
CARE cash_flow (quarterly, 2026-03-31) — End Cash Position: 228318000.00
CARE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -154139000.00
CARE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 302378000.00
CARE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -80000.00
CARE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 80000.00
CARE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -42970000.00
CARE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 16425000.00
CARE balance_sheet (quarterly, 2026-03-31) — Goodwill: 1193000.00
CARE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2067000.00
CARE income_statement (quarterly, 2026-03-31) — Insurance And Claims: 1510000.00
CARE income_statement (quarterly, 2026-03-31) — Interest Expense: 23251000.00
CARE income_statement (quarterly, 2026-03-31) — Interest Income: 58940000.00
CARE cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 23927000.00
CARE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -26621000.00
CARE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 672373000.00
CARE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 299000000.00
CARE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 299000000.00
CARE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -477500000.00
CARE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 2774000.00
CARE income_statement (quarterly, 2026-03-31) — Net Income: 85757000.00
CARE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 84688000.00
CARE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 85757000.00
CARE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 85757000.00
CARE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 85757000.00
CARE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 85757000.00
CARE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 85757000.00
CARE income_statement (quarterly, 2026-03-31) — Net Interest Income: 35689000.00
CARE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 27955000.00
CARE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -178500000.00
CARE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -178500000.00
CARE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 8354000.00
CARE balance_sheet (quarterly, 2026-03-31) — Net PPE: 70968000.00
CARE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1537000.00
CARE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 502835000.00
CARE income_statement (quarterly, 2026-03-31) — Normalized Income: 85757000.00
CARE income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 4861000.00
CARE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 303915000.00
CARE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -109000.00
CARE income_statement (quarterly, 2026-03-31) — Operating Revenue: 105907000.00
CARE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 22159980.00
CARE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -42970000.00
CARE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 874000.00
CARE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 224511000.00
CARE income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 6253000.00
CARE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 355645000.00
CARE income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 1069000.00
CARE income_statement (quarterly, 2026-03-31) — Pretax Income: 110031000.00
CARE income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 1546000.00
CARE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -3500000.00
CARE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1537000.00
CARE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2132000.00
CARE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -477500000.00
CARE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 450725000.00
CARE income_statement (quarterly, 2026-03-31) — Salaries And Wages: 14915000.00
CARE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 31455000.00
CARE income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 926000.00
CARE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 17351000.00
CARE balance_sheet (quarterly, 2026-03-31) — Share Issued: 22159980.00
CARE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 519000.00
CARE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 504902000.00
CARE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 502835000.00
CARE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CARE income_statement (quarterly, 2026-03-31) — Tax Provision: 24274000.00
CARE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
CARE balance_sheet (quarterly, 2026-03-31) — Total Assets: 4799270000.00
CARE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 504902000.00
CARE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4294368000.00
CARE cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 45000.00
CARE income_statement (quarterly, 2026-06-30) — Basic Average Shares: 21838645.00
CARE income_statement (quarterly, 2026-06-30) — Basic EPS: 1.31
CARE income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 21838645.00
CARE income_statement (quarterly, 2026-06-30) — Diluted EPS: 1.31
CARERATING.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -155875000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 739206000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -22710000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Amortization: 6195000.00
CARERATING.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 6195000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 29510126.00
CARERATING.NS income_statement (annual, 2022-03-31) — Basic EPS: 25.45
CARERATING.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 725170000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 109734000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 66591000.00
CARERATING.NS cash_flow (annual, 2022-03-31) — Change In Receivables: 47146000.00
CARERATING.NS cash_flow (annual, 2022-03-31) — Common Stock Payments: 0.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Current Deferred Assets: 67895000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 2130000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 29674569.00
CARERATING.NS income_statement (annual, 2022-03-31) — Diluted EPS: 25.31
CARERATING.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 2554000.00
CARERATING.NS cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 0.00
CARERATING.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 95416000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 189121000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Held To Maturity Securities: 190696000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 2129000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Interest Income: 247731000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 247731000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 201118000.00
CARERATING.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 1000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 116634000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 17528000.00
CARERATING.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Other Payable: 50096000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 19184000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 159468000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
CARERATING.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 4268000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 4268000.00
CARERATING.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: 0.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 25150000.00
CARERATING.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 3041061000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 13095000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 108511000.00
CARERATING.NS income_statement (annual, 2022-03-31) — Write Off: 3783000.00
CARERATING.NS income_statement (annual, 2023-03-31) — +Operating Expense: 602467000.00
CARERATING.NS income_statement (annual, 2023-03-31) — +Total Revenue: 2789930000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 102700000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 203808000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -209022000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 759774000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -29430000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Amortization: 5308000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 5308000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 556242000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 29655883.00
CARERATING.NS income_statement (annual, 2023-03-31) — Basic EPS: 28.17
CARERATING.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 176326000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 732175000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -115064000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 174781000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 297005000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 494247000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 5647675000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -597637000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 421648000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 72599000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -2787000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 86761000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -42764000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 41210000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 317921000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Common Stock: 297005000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 6722079000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 24238000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Common Stock Payments: -18502000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 1241110000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Current Assets: 6017874000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 22012000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 22012000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 2801000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 578099000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 72165000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Depreciation: 99986000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 105294000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 105294000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 99986000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 29655883.00
CARERATING.NS income_statement (annual, 2023-03-31) — Diluted EPS: 28.17
CARERATING.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 835294000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2462000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 3160000.00
CARERATING.NS income_statement (annual, 2023-03-31) — EBIT: 1267481000.00
CARERATING.NS income_statement (annual, 2023-03-31) — EBITDA: 1372775000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 0.00
CARERATING.NS cash_flow (annual, 2023-03-31) — End Cash Position: 494247000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -633306000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 707360000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -8691000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 81000.00
CARERATING.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 107854000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Goodwill: 79503000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 141619000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 244568000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 973520000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Gross Profit: 1548820000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 189807000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 57062000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Interest Expense: 10016000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 10016000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Interest Income: 350495000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 350495000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -10016000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 184104000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 6722079000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 128803000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 556242000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 24238000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 152769000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 152769000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 125513000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 259649000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 68333000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Minority Interests: -19286000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 5736000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -11173000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Income: 835294000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 835294000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 854580000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 835294000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 835294000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1257465000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 854580000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Interest Income: 340479000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 56340000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 340479000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -2120000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Net PPE: 973520000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -114801000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 6580460000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 49391000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 125513000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 14255000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1424914000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Normalized Income: 870727945.77
CARERATING.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 822424000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Operating Income: 946353000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Operating Revenue: 2789930000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 29700612.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 121293000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 218240000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 6425074000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 62116000.00
CARERATING.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -311729000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 3543000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 8436000.00
CARERATING.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 235918000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Payable: 22199000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Properties: 973520000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 2905000.00
CARERATING.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 5153428000.00